Liquidia Corporation (LQDA)
NASDAQ: LQDA
· Real-Time Price · USD
21.80
-0.65 (-2.90%)
At close: Sep 26, 2025, 3:59 PM
21.95
0.69%
After-hours: Sep 26, 2025, 05:56 PM EDT
-2.90% (1D)
Bid | 21.13 |
Market Cap | 1.88B |
Revenue (ttm) | 19.32M |
Net Income (ttm) | -99.89M |
EPS (ttm) | -1.82 |
PE Ratio (ttm) | -11.98 |
Forward PE | 34.28 |
Analyst | Buy |
Dividends | n/a |
Ask | 22.61 |
Volume | 3,679,966 |
Avg. Volume (20D) | 2,750,142 |
Open | 22.16 |
Previous Close | 22.45 |
Day's Range | 21.14 - 22.40 |
52-Week Range | 9.71 - 29.94 |
Beta | 0.23 |
Ex-Dividend Date | n/a |
About LQDA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LQDA
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LQDA stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsLiquidia Corporation is scheduled to release its earnings on
Nov 12, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+13.68%
Liquidia shares are trading higher. The company re...
Unlock content with
Pro Subscription
3 months ago
-16.87%
Liquidia shares are trading lower in reaction to Insmed after its drug to treat rare lung disease met its primary endpoint and all secondary efficacy endpoints.

1 month ago · seekingalpha.com
Liquidia Corporation (LQDA) Q2 2025 Earnings Call TranscriptLiquidia Corporation (LQDA) Q2 2025 Earnings Call Transcript